PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.15%
Some net income increase while MRVL is negative at -39.69%. John Neff would see a short-term edge over the struggling competitor.
2.49%
Some D&A expansion while MRVL is negative at -0.14%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-112.50%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
13.11%
SBC growth well above MRVL's 4.86%. Michael Burry would flag major dilution risk vs. competitor’s approach.
67.77%
Well above MRVL's 15.39% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
95.88%
AR growth while MRVL is negative at -162.67%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-38.46%
Both reduce yoy inventory, with MRVL at -100.09%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-124.64%
Negative yoy AP while MRVL is 1033.48%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
52.00%
Lower 'other working capital' growth vs. MRVL's 199.88%. David Dodd would see fewer unexpected short-term demands on cash.
-2750.00%
Negative yoy while MRVL is 321.11%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
14.65%
Operating cash flow growth at 50-75% of MRVL's 28.58%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-25.32%
Negative yoy CapEx while MRVL is 47.16%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
29.83%
Purchases growth of 29.83% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
22.75%
Liquidation growth of 22.75% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1878.95%
Both yoy lines negative, with MRVL at -94.89%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
111.45%
Investing outflow well above MRVL's 46.34%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-72.45%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-46.00%
Both yoy lines negative, with MRVL at -0.04%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.